Skip to content

Non-pharmacological Interventions for People With Mild Cognitive Impairment in the Community

Development of a 'Community-Family Mutual Support' Intervention Model for Patients With Mild Cognitive Impairment Based on Social Support Theory

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07703267
Acronym
CNPI-MCI
Enrollment
70
Registered
2026-07-14
Start date
2026-07-28
Completion date
2026-10-28
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment (MCI)

Brief summary

Mild cognitive impairment (MCI) may increase the risk of dementia. This study will evaluate an 8-week community-family mutual support intervention for adults aged 60 years or older with MCI. Participants will be randomly assigned to an intervention group or a control group. The control group will receive routine community care, while the intervention group will additionally receive cognitive training, health education, family support, mutual support activities, and individualized feedback. Cognitive function, daily functioning, emotional status, and social support will be assessed before and after the intervention.

Interventions

OTHERCommunity-Family Mutual Support Intervention

Participants will receive an 8-week community-family mutual support intervention in addition to routine community care. Guided by social support theory, the program integrates informational, emotional, instrumental, and appraisal support. It includes MCI-related health education, cognitive training, physical activity guidance, emotional self-monitoring, home-based practice with family assistance, mutual support between paired families, group activities, and individualized feedback. The intervention will be delivered through community-based sessions and supported home activities by trained researchers and community nurses.

Participants will receive routine community care, including standard health education and usual community-based health services, during the 8-week study period. They will not receive the community-family mutual support intervention.

Sponsors

Anhui Medical University
Lead SponsorOTHER
The First Affiliated Hospital of Anhui Medical University
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 60 years or older. * Meets the diagnostic criteria for mild cognitive impairment, including subjective cognitive decline, objective impairment in at least one cognitive domain, relatively preserved activities of daily living, and no diagnosis of dementia. * Has lived in the study community for at least 6 months. * Has completed primary school or above and is able to read and write. * Is able to communicate and complete the study assessments and intervention activities. * Voluntarily participates and provides written informed consent.

Exclusion criteria

* Unable to communicate effectively. * Has severe visual or hearing impairment that prevents participation. * Has dementia, schizophrenia, or another severe psychiatric disorder. * Has a serious or unstable physical illness that prevents participation in the intervention. * Is currently participating in another cognitive training or similar intervention study.

Design outcomes

Primary

MeasureTime frame
Change in Cognitive Function Assessed by the Montreal Cognitive Assessment (MoCA)From enrollment to the end of treatment at 8 weeks

Secondary

MeasureTime frameDescription
Change From Baseline in Social Support Rating Scale (SSRS) Total ScoreFrom enrollment to the end of treatment at 8 weeksSocial support will be assessed using the 10-item Social Support Rating Scale (SSRS). The total score ranges from 12 to 66 points, with higher scores indicating greater social support. The outcome measure is the change in the total score from baseline to Week 8.
Change From Baseline in Patient Health Questionnaire-9 (PHQ-9) Total ScoreFrom enrollment to the end of treatment at 8 weeksDepressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9). Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27. Higher scores indicate more severe depressive symptoms. The outcome measure is the change in the PHQ-9 total score from baseline to Week 8.

Contacts

CONTACTYiran Yue
yueyiran1@163.com8617333266696

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026